PCLG yields 0.04% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 4
Combined, PCLG + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PCLG + JNJ for your $10,000?
PCLG aims for long-term capital growth by investing in about 25 to 40 large-cap companies located in both developed and emerging markets. The fund selects growth stocks perceived to have consistent earnings growth. In addition, the fund considers a companys competitive advantage within an industry with high barriers to entry. Characteristics include consistent and sustainable return to capital, as well as strong earnings growth, free cash flow, balance sheets, and management teams. The fund invests in growth stocks from at least three different countries, targeting 30-40% non-US securities, depending on its assessment of global market conditions. The sub-advisor integrates ESG factors in its evaluation of long-term financial sustainability. As an actively managed ETF, the fund has full discretion to adjust holdings at any time. The fund launched with 109.4 million in assets.
Full PCLG Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.